|1.97||-0.09 / -4.37%|
As of 3:59pm ET
|2.03||+0.055 / +2.79%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +331.47% increase from the last price of 1.97.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.